These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Efficacy of tetracycline and metronidazole alone or with ranitidine on the healing of duodenal ulcer and eradication of Helicobacter pylori. A randomized controlled multicenter study. Tetra-Metro-Ran Study Group. Massarrat S; Ihm P; Koch HK Arzneimittelforschung; 1998 Jun; 48(6):686-90. PubMed ID: 9689428 [TBL] [Abstract][Full Text] [Related]
43. New developments in Helicobacter pylori eradication therapy. Pounder RE Scand J Gastroenterol Suppl; 1997; 223():43-5. PubMed ID: 9200305 [TBL] [Abstract][Full Text] [Related]
44. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer. Iser JH; Buttigieg RJ; Iseli A Med J Aust; 1994 Feb; 160(4):192-6. PubMed ID: 7906009 [TBL] [Abstract][Full Text] [Related]
45. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer]. Buzás György M; Székely E; Illyés G; Széles I Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194 [TBL] [Abstract][Full Text] [Related]
46. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens. Xia HX; Gilvarry J; Beattie S; Hamilton H; Keane CT; Sweeney EC; O'Morain CA Am J Gastroenterol; 1995 Aug; 90(8):1221-5. PubMed ID: 7639218 [TBL] [Abstract][Full Text] [Related]
48. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial. Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068 [TBL] [Abstract][Full Text] [Related]
49. Acid suppression with ranitidine plus oral triple therapy improves ulcer healing but not Helicobacter pylori eradication. Magalhaes AF; Macedo C; Hauck JR; Carvalhaes A; De Nucci G; Magna LA; Pedrazzoli J Hepatogastroenterology; 1998; 45(24):2161-4. PubMed ID: 9951885 [TBL] [Abstract][Full Text] [Related]
50. Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control. Schütze K; Hentschel E; Hirschl AM Hepatogastroenterology; 1999; 46(28):2358-62. PubMed ID: 10521998 [TBL] [Abstract][Full Text] [Related]
51. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy. de Boer WA; Haeck PW; Otten MH; Mulder CJ Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338 [TBL] [Abstract][Full Text] [Related]
52. Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial. Marshall BJ; Valenzuela JE; McCallum RW; Dooley CP; Guerrant RL; Cohen H; Frierson HF; Field LG; Jerdack GR; Mitra S Dig Dis Sci; 1993 Sep; 38(9):1674-80. PubMed ID: 8359080 [TBL] [Abstract][Full Text] [Related]
53. Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy. Chong SK; Lou Q; Asnicar MA; Zimmerman SE; Croffie JM; Lee CH; Fitzgerald JF Pediatrics; 1995 Aug; 96(2 Pt 1):211-5. PubMed ID: 7630671 [TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease. Jönsson B Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390 [TBL] [Abstract][Full Text] [Related]
55. Peptic ulcer and duodenal stenosis: role of Helicobacter pylori infection. Annibale B; Marignani M; Luzzi I; Delle Fave GF Ital J Gastroenterol; 1995; 27(1):26-8. PubMed ID: 7795284 [TBL] [Abstract][Full Text] [Related]
56. Ranitidine bismuth citrate plus clarithromycin for the eradication of H. pylori. Dixon JS; Pipkin GA; Mills JG; Wood JR J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():47-58. PubMed ID: 9440055 [TBL] [Abstract][Full Text] [Related]
57. [Therapy of peptic ulcer and chronic gastritis with bismuth salts]. Rösch W Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149 [TBL] [Abstract][Full Text] [Related]
58. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy. Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464 [TBL] [Abstract][Full Text] [Related]
59. Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen. Kahramanoğlu Aksoy E; Pirinçci Sapmaz F; Göktaş Z; Uzman M; Nazlıgül Y Med Princ Pract; 2017; 26(6):523-529. PubMed ID: 29131124 [TBL] [Abstract][Full Text] [Related]
60. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial. Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]